Single Cell Diagnostics

Multiplex RNA in situ Hybridization, Multiplex Protein Detection,

DNA/Cell Cycle, Simultaneously…in Every Cell!


Our Mission


IncellDx, Inc. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers.

Our Products

Recognizing every cell tells a story we are dedicated to revolutionizing healthcare one cell at a time. Combining proprietary molecular diagnostics with cellular analysis, we offer diagnostic, prognostic and therapeutic clinical information for physicians to make more informed clinical decisions.

HPV OncoTect 3Dx™

More than 450,000 new cases of cervical cancer are diagnosed each year. Our CE-IVD HPV OncoTect 3Dx™  for in vitro diagnostics is a unique quantative cell based assay that measures both mRNA E6 and E7.

Learn More

Cytokine and Receptor Occupancy Kits
news flashside-by-side-02
COVID Long Haulers Website

Visit our new COVID Long Haulers website and register for a incellKINE Test.

Learn More

Press Releases

Breaking News!
Read our new article posted in ASHI Quarterlynews flashPreview

The Long-Haul Role of Laboratory Diagnostics Post-COVID
IncellDx presents at International TLC Conference
news flash

IncellDx CEO Bruce Patterson to Present on Potential Pathways for Diagnosing and Treating Long COVID at the International TLC Conference

IncellDx’s Next Gen HPV/Cervical Cancer Assay (HPV OncoTect 3Dx) Receives Clinical Approval from Costa Rican Ministry of Health

Learn More